Journal issues > Issue SPECIAL, November 2020 > Educational session: coagulopathy and thromboprophylaxis in COVID-19 times

Educational session: coagulopathy and thromboprophylaxis in COVID-19 times

By: A. Dekker MD, T. Feys MBA, MSc

Jan Emmerechts and Christelle Orlando moderated the educational session of the 28^th annual BSTH meeting focusing on the management of thromboprophylaxis and anticoagulation in critically ill patients during the COVID-19 pandemic. Prof. dr. M. Levi (University College London, London, United Kingdom) opened the session with a presentation on the latest evidence on the effects of a COVID-19 infection on thromboprophylaxis and coagulopathy. This presentation was followed up by Prof. Dr. T. Vanassche (University Hospitals Leuven and McMaster University, Hamilton) who gave a brief introduction on the new BSTH consensus guideline on anti-coaguation in patients with COVID-19. Finally, Dr D.J. Arachchillage (Hammersmith hospital in Imperial College Healthcare NHS Trust and Royal Brompton Hospital, London, United Kingdom) discussed the challenges of anticoagulation in critical care patients and in patients on mechanical cardiopulmonary support.

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top